1/5/2017 | BKCVIG | Moody’s drops St. Jude notes to Baa3
|
1/5/2017 | BKCVIG | Fitch lowers Abbott, St. Jude
|
1/5/2017 | BKCVIG | S&P lowers St. Jude Medical
|
4/28/2016 | BKCVIG | Fitch puts St. Jude on watch
|
4/28/2016 | BKCVIG | Moody’s could lower St. Jude
|
10/9/2015 | BKCVIG | Moody’s lowers St. Jude
|
10/8/2015 | BKCVIG | S&P downgrades St. Jude
|
9/17/2015 | BKCVIG | S&P: St. Jude on watch on acquisition news
|
9/15/2015 | EMHYMUPFPV | Market Commentary: American Campus upsizes; UDR, AEP Texas price notes; Disney tightens; credit spreads firm
|
9/15/2015 | IG | Market Commentary: American Campus upsizes; UDR, AEP Texas price notes; Disney tightens; credit spreads firm
|
9/15/2015 | IG | Market Commentary: Morning Commentary: St. Jude Medical improves in secondary market; Biogen notes remain tight
|
9/14/2015 | EMHYMUPFPV | Market Commentary: Walt Disney, St. Jude price ahead of Fed decision; Lowe’s bonds strong in secondary
|
9/14/2015 | IG | Market Commentary: Walt Disney, St. Jude price ahead of Fed decision; Lowe’s bonds strong in secondary
|
9/14/2015 | IG | New Issue: St. Jude Medical sells $1.5 billion three-, five-, 10-year notes
|
9/14/2015 | BKCVIG | S&P rates St. Jude Medical notes A, places on watch
|
9/14/2015 | BKCVIG | Fitch lowers St. Jude, rates notes A-
|
9/14/2015 | BKCVIG | Moody’s rates St. Jude notes, loans Baa2
|
9/14/2015 | IG | St. Jude Medical plans to sell three-, five-, 10-year notes on Monday
|
8/28/2015 | CVIG | S&P rates St. Jude loan A
|
8/24/2015 | BK | St. Jude Medical obtains $2.6 billion in term loans, extends revolver
|
7/22/2015 | CVIG | Fitch puts St. Jude on watch
|
7/22/2015 | CVIG | S&P: St. Jude Medical on negative watch
|
7/22/2015 | CV | S&P: St. Jude Medical on negative watch
|
7/22/2015 | CV | S&P: St. Jude Medical on negative watch
|
7/22/2015 | IG | Moody’s reviews St. Jude
|
7/22/2015 | BKIG | St. Jude Medical eyes new loan, notes to fund Thoratec acquisition
|
3/25/2013 | IG | Market Commentary: Midday Commentary: Secondary market sees St. Jude, Westar Energy notes tighten in trading
|
3/25/2013 | IG | Market Commentary: GE Capital, Assurant, Carlyle sales kick off holiday week; St. Jude tightens in secondary
|
3/22/2013 | IG | Market Commentary: Midday Commentary: Subdued session expected as St. Jude notes firm, Westar slightly wider
|
3/22/2013 | IG | Market Commentary: Citigroup caps $20 billion week with sale; coming holiday week quieter; St. Jude notes firm
|
3/21/2013 | CVIG | Moody's: St. Jude notes Baa1
|
3/21/2013 | IG | New Issue: St. Jude Medical prices $1.6 billion notes in 10-, 30-year maturities
|
3/21/2013 | IG | Market Commentary: SMBC, Swedbank, UBS, St. Jude among new deals; Westar tightens, trading volumes 'very light'
|
3/21/2013 | IG | St. Jude Medical prepares 10-, 30-year senior notes for Thursday sale
|
3/21/2013 | IGLM | St. Jude to redeem 3.75%, 4.875% notes with new offering proceeds
|
3/21/2013 | CVIG | S&P rates St. Jude notes A
|
12/18/2012 | SP | New Issue: Deutsche Bank prices $1.88 million trigger phoenix autocallables tied to St. Jude Medical
|
12/17/2012 | SP | New Issue: JPMorgan prices $514,000 5.2% reverse convertibles linked to St. Jude
|
12/12/2012 | SP | Deutsche Bank plans trigger phoenix autocallables on St. Jude Medical
|
6/25/2012 | SP | New Issue: JPMorgan prices $1.82 million 13.25% reverse convertibles linked to St. Jude
|
6/5/2012 | SP | JPMorgan plans 12.5%-16.5% reverse exchangeables linked to St. Jude
|
10/13/2011 | CVIG | Fitch affirms St. Jude
|
12/1/2010 | CVIG | Moody's: St. Jude note at Baa1
|
12/1/2010 | IG | New Issue: St. Jude Medical sells $500 million 2.5% five-year notes at 90 bps over Treasuries
|
12/1/2010 | IG | Market Commentary: Eastman Chemical, Cigna, St. Jude, IDEX among deals; Citi remarkets; financials mixed
|
12/1/2010 | CVIG | S&P rates St. Jude notes A
|
12/1/2010 | CVIG | Fitch rates St. Jude, notes A
|
10/18/2010 | IG | Moody's cuts St. Jude view to stable
|
10/18/2010 | IG | Fitch affirms St. Jude
|
7/23/2010 | IG | Fitch affirms St. Jude Medical
|
3/10/2010 | IG | Moody's rates St. Jude notes Baa1
|
3/10/2010 | IG | Fitch rates St. Jude notes A
|
3/10/2010 | IG | Market Commentary: Cliffs, St. Jude, Airgas, PartnerRe sell notes, Citi prices trust preferreds; deals trade well
|
3/10/2010 | IG | New Issue: St. Jude Medical prices $450 million 2.2% notes due 2013 at Treasuries plus 80 bps
|
3/10/2010 | IG | S&P rates St. Jude notes A
|
7/28/2009 | IG | Market Commentary: Primary quiet after earnings streak; Northrop stays firm, St. Jude gains more; spreads wider
|
7/24/2009 | IG | Market Commentary: Primary empties, coming week seen busier; Boeing, Bank of America unchanged, St. Jude gains
|
7/23/2009 | IG | S&P rates St. Jude notes A
|
7/23/2009 | IG | Moody's rates St. Jude notes Baa1
|
7/23/2009 | IG | Market Commentary: Boeing, St. Jude Medical, Bank of America sells bonds, tone turns upbeat; spreads tighter
|
7/23/2009 | IG | New Issue: St. Jude Medical sells $1.2 billion notes in five, 10-year tranches
|
7/22/2009 | CVIG | St. Jude Medical files shelf registration covering debt, preferreds
|
7/17/2009 | CVIG | Fitch rates St. Jude A
|
6/5/2009 | IG | S&P upgrades St. Jude Medical
|
7/16/2008 | CV | Market Commentary: Alpha Natural merger hurts hedge funds; financials rebound; St. Jude up on results; Trina Solar plans deal
|
7/7/2008 | SS | St. Jude completes acquisition of EP MedSystems
|
7/2/2008 | SS | Final exchange ratio announced in merger of St. Jude Medical, EP MedSystems
|
6/26/2008 | SS | EP MedSystems, St. Jude Medical merger set to close July 3
|
4/9/2008 | SS | Market Commentary: Microsoft's threats to go hostile and lower its bid for Yahoo! are counterproductive, ICAP analyst says
|
4/9/2008 | SS | St. Jude to boost atrial fibrillation product line with $92.1 million acquisition of EP MedSystems
|
3/28/2008 | SP | New Issue: Barclays prices $2 million 9% reverse convertibles linked to St. Jude
|
3/11/2008 | SP | Barclays to price 9% reverse convertibles linked to St. Jude
|
1/24/2008 | CVIG | S&P: St. Jude view positive
|
1/9/2008 | CV | Market Commentary: Countrywide, REITs head lower; financials, health care in focus; market pares early losses; Thornburg plans deal
|
10/23/2007 | CV | Market Commentary: Level 3 hammered on earnings; Countrywide down on borrower bailout; Medtronic coming back?
|
10/19/2007 | CV | Market Commentary: Gilead falls after positive earnings; Medtronic drags down St. Jude; AMD weighs down Intel; Yahoo! gives back
|
10/18/2007 | CV | Market Commentary: CIT active but stays still; Medtronic continues slide; St. Jude down; Nektar tumbles as Pfizer pulls drug
|
9/27/2007 | CV | Market Commentary: General Cable well-received; GM, Ford slip; AMR flies high on Icelandic air; St. Jude, LifePoint up
|
7/26/2007 | SP | New Issue: Barclays prices $1.5 million 10.75% reverse convertibles linked to St. Jude
|
7/25/2007 | CV | Convertible analyst Berkman identifies safe harbors in choppy market seas
|
7/10/2007 | SP | Barclays to price 10.75% reverse convertibles linked to St. Jude
|
6/27/2007 | SP | New Issue: RBC sells $104,000 11% reverse convertibles linked to St. Jude Medical
|
6/27/2007 | SP | New Issue: RBC sells $130,000 9% reverse convertibles linked to St. Jude Medical
|
6/18/2007 | SP | New Issue: Barclays prices $2 million 11.5% reverse convertibles linked to St. Jude
|
6/15/2007 | SP | RBC to price 11% reverse convertibles linked to St. Jude Medical
|
6/15/2007 | SP | RBC to price 9% reverse convertibles linked to St. Jude Medical
|
6/15/2007 | SP | New Issue: Barclays sells $2 million 11.5% reverse convertibles linked to St. Jude
|
5/29/2007 | SP | New Issue: Barclays prices $1.5 million 9.5% reverse convertibles linked to St. Jude
|
5/9/2007 | SP | Barclays to price 9.5% reverse convertibles linked to St. Jude Medical
|
4/30/2007 | CV | Market Commentary: Tyco continues gains amid tender offer; MedImmune up ahead of earnings; issuance grows in April
|
4/20/2007 | CV | New Issue: St. Jude prices $1.2 billion 20-month convertibles within talk at 1.22%, up 20%
|
4/20/2007 | CV | Market Commentary: St. Jude gains on debut; BankUnited slips with stock; Delta Petroleum quiet; Archer Daniels better to sell
|
4/19/2007 | CV | St. Jude Medical prices $1.2 billion 20-month convertibles at 1.22%, up 20%, greenshoe exercised
|
4/19/2007 | CV | S&P gives St. Jude Medical convertibles BBB+
|
4/19/2007 | CV | Market Commentary: Linear gains on debut; Delta improves, BankUnited slips, St. Jude quiet in gray; International Game eases
|
1/26/2007 | SP | New Issue: HSBC prices $250,000 8.25% notes linked to St. Jude Medical
|
1/8/2007 | SP | HSBC to issue 8.25% reverse convertibles linked to St. Jude
|
12/22/2006 | SP | New Issue: Barclays sells $3 million 9.25% reverse convertibles linked to St. Jude
|
12/4/2006 | SP | Barclays to price 9.25% reverse convertibles linked to St. Jude
|
11/28/2006 | SP | New Issue: HSBC USA sells $744,000 of 8.5% notes linked to St. Jude
|
11/6/2006 | SP | HSBC to issue 8.5% reverse convertibles linked to St. Jude
|
10/18/2006 | BT | RBC keeps St. Jude sector perform rating
|
10/18/2006 | BT | St. Jude Medical: net sales for the quarter up 11%, net earnings reach $116 million
|
10/18/2006 | CV | Market Commentary: St. Jude flat, drags Medtronic lower; AMR gains on profit; Home Properties, Minefinders quiet in the gray
|
9/19/2006 | BT | St. Jude Medical gets approvals for Tendril ST pacemaker lead
|
9/19/2006 | BT | St. Jude Medical to increase annual earnings per share by 15%; says ICD market will grow
|
9/14/2006 | CV | New Issue: Eksportfinans sells $1 million 9% notes linked to St. Jude Medical
|
8/28/2006 | BT | St. Jude Medical to merge cardiac surgery, cardiology divisions
|
8/22/2006 | BT | St. Jude Medical gets FDA approval for QuickOpt timing cycle for heart disease
|
8/3/2006 | BT | St. Jude kept at market perform by JMP
|
8/3/2006 | CV | Market Commentary: Medtronic, DRS fall outright on poor guidance; Transocean slides on miss; CompuCredit declines
|
8/2/2006 | CV | Market Commentary: Ford revs up on new advisor; Medtronic, St. Jude gain on Medicare changes; Huntsman gets results boost
|
7/31/2006 | BT | St. Jude Medical, Boston Scientific settle litigation related to four patents
|
7/27/2006 | BT | New Issue: Conor raises $96.25 million in follow-on of 3.5 million shares at $27.50 each vs. $27.75 close
|
7/20/2006 | BT | St. Jude Medical kept at sector perform by RBC
|
7/20/2006 | BT | JMP maintains St. Jude Medical at market perform
|
7/19/2006 | BT | St. Jude Medical second-quarter net sales up 15% at $833 million
|
7/18/2006 | BT | St. Jude Medical gets FDA approval for heart-failure devices
|
7/5/2006 | BT | St. Jude Medical kept at market perform by JMP
|
6/16/2006 | BT | St. Jude cardiac resynchronization therapy approved in Europe
|
6/14/2006 | BT | St. Jude Medical to sell two electrophysiology products in Europe
|
6/13/2006 | BT | St. Jude Medical's Epic II devices for heart arrhythmias, failure, receive CE Mark approval
|
5/17/2006 | BT | FDA approves St. Jude Medical's Safire catheter, clears Optima PLUS steerable catheter
|
5/16/2006 | BT | St. Jude Medical gets FDA approval for two heart-failure devices
|
5/8/2006 | BT | Advanced Neuromodulation gets CE Mark for rechargeable neurostimulator
|
5/2/2006 | BT | St. Jude Medical announces regulatory approvals, market launch of QuickSite XL lead
|
4/20/2006 | CV | Market Commentary: General Motors gains, Intel falls on quarterly results; Gilead new deal stumbles on debut;
|
4/20/2006 | BTCV | S&P: St. Jude Medical unaffected
|
4/19/2006 | BT | St. Jude Medical first-quarter sales up 18%
|
4/18/2006 | BT | FDA approves St. Jude Medical's heart failure lead delivery system
|
4/18/2006 | BT | St. Jude Medical announces first implant in migraine headache study
|
4/17/2006 | BT | St. Jude Medical gets approval, prepares market launch for cardiac-care device
|
4/10/2006 | BT | St. Jude gets FDA regulatory, market approval for world's thinnest ICD lead
|
4/5/2006 | BT | JMP downgrades St. Jude to market perform
|
4/5/2006 | BT | St. Jude kept at peer perform by Bear Stearns
|
4/4/2006 | BT | St. Jude Medical's first-quarter net sales, defibrillator revenues fall below guidance
|
3/29/2006 | BT | St. Jude develops more affordable leukemia test
|
3/17/2006 | BT | St. Jude Medical launches new vascular closure device
|
3/2/2006 | BT | St. Jude Medical to test if treatment of common heart defect alleviates migraines
|
2/13/2006 | BT | JMP reiterates St. Jude Medical at strong buy
|
2/7/2006 | BT | St. Jude Medical pacemakers receive FDA approval
|
1/26/2006 | BT | JMP keeps St. Jude Medical at strong buy
|
1/10/2006 | BT | St. Jude Medical says use of defibrillator with drugs cut shocks in study
|
1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
1/5/2006 | BT | JMP reiterates St. Jude at strong buy
|
12/7/2005 | CV | Market Commentary: XL Capital, Aspen Insurance, St. Jude lift slightly; SafeNet prices; Calpine grinds lower
|
12/7/2005 | BTCV | S&P rates St. Jude convertibles BBB+
|
12/6/2005 | CV | Market Commentary: Kansas City Southern gains on debut; U.S. Bancorp steady after re-offer; St. Jude Medical prices
|
12/6/2005 | BTCV | New Issue: St. Jude Medical $600 million 30-year convertibles yield 2.8%, up 25%
|
12/5/2005 | CV | Market Commentary: U.S. Bancorp brings $2 billion; Kansas City Southern, St. Jude, Omnicare also launch; Calpine down
|
12/5/2005 | BTCV | St. Jude Medical $600 million 30-year convertibles talked to yield 2.375%-2.875%, up 25%
|
12/1/2005 | BT | St. Jude to acquire Savacor for $50 million to further heart failure research
|
12/1/2005 | BT | St. Jude receives FDA approval for Cardiac Ablation Generator and Therapy catheters
|
10/27/2005 | BT | St. Jude gets approval to sell Victory pacemakers in Europe
|
10/26/2005 | BT | JMP maintains St. Jude at strong buy
|
10/18/2005 | BT | St. Jude maintained by JMP at strong buy
|
10/17/2005 | BT | St. Jude Medical to acquire Advanced Neuromodulation Systems for $1.3 billion
|
9/27/2005 | BT | St. Jude initiated by JMP at strong buy
|